Clinical Trial Update: Effect of PCSK9 Inhibitor on Retinal Microvessels in Patients With Coronary Heart Disease After Intensive Lipid-lowering Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of a PCSK9 inhibitor on retinal microvasculature in coronary heart disease patients after intensive lipid-lowering …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Retinal Microvascular Disease

Drugs mentioned

• PCSK9 inhibitor (PCSK9 inhibitor)

Snippet

Sponsor: Zibo Central Hospital | Conditions: Adverse Effect of Cardiovascular Medications (Diagnosis) | Phase 4 | Status: UNKNOWN